GLP-Compliant Preclinical CRO · India
Investor Relations
AOA and MOA
Committees
Committees Document
PDF • Updated Jan 2024
Codes and Policies
Archival Policy
PDF • Compliance Document
Code for Independent Directors
PDF • Compliance Document
Code of Conduct for Directors
PDF • Compliance Document
Code of Practices and Procedures for Fair Disclosure of UPSI
PDF • Compliance Document
Policy on Related Party Transactions
PDF • Compliance Document
Remuneration Policy
PDF • Compliance Document
Vigil Mechanism Policy
PDF • Compliance Document
Policy On Disclosure & Materiality
PDF • Compliance Document
Risk Management Policy
PDF • Compliance Document
Dividend Distribution Policy
PDF • Compliance Document
POSH Policy
PDF • Compliance Document
Archival Policy
PDF • Compliance Document
Independent Directors — Appointment Letters
Grievance Redressal
Grievance Redressal Document
PDF • Updated Feb 2025
Annual Report
Annual Report FY 2016-17
PDF • Annual Corporate Filing
Annual Report FY 2017-18
PDF • Annual Corporate Filing
Annual Report FY 2018-19
PDF • Annual Corporate Filing
Annual Report FY 2019-20
PDF • Annual Corporate Filing
Annual Report FY 2020-21
PDF • Annual Corporate Filing
Annual Report FY 2021-22
PDF • Annual Corporate Filing
Annual Report FY 2022-23
PDF • Annual Corporate Filing
Annual Report FY 2023-24
PDF • Annual Corporate Filing
Annual Report FY 2024-25
PDF • Annual Corporate Filing
Annual Returns
Annual-Return 2016-17
PDF • Statutory Return
Annual-Return 2017-18
PDF • Statutory Return
Annual-Return 2018-19
PDF • Statutory Return
Annual-Return 2019-20
PDF • Statutory Return
Annual-Return 2020-21
PDF • Statutory Return
Annual-Return 2021-22
PDF • Statutory Return
Annual-Return 2022-23
PDF • Statutory Return
Financial Results
Unaudited Results – H1FY2017-18
PDF • Financial Statement
Audited Results – FY 2017-18
PDF • Financial Statement
Unaudited Results – H1FY2018-19
PDF • Financial Statement
Audited Results – FY 2018-19
PDF • Financial Statement
Unaudited Results – H1 FY 2019-2020
PDF • Financial Statement
Audited Results – FY 2019-20
PDF • Financial Statement
Unaudited Results – H1FY2020-21
PDF • Financial Statement
Audited Results – FY 2020-21
PDF • Financial Statement
Unaudited Results – H1 FY 2022-23
PDF • Financial Statement
Audited Results – FY 2022-23
PDF • Financial Statement
Unaudited Results – H1 FY 2023-24
PDF • Financial Statement
Audited Results – FY 2023-24
PDF • Financial Statement
Unaudited Results – H1 FY 2024-25
PDF • Financial Statement
Audited Results FY 2024-25
PDF • Financial Statement
Unaudited Results H1 FY 2025-26
PDF • Financial Statement
Financials of Subsidiaries
VANTA CLINICAL RESEARCH LIMITED
Subsidiary Financials FY 2018-19
PDF • Vanta Clinical Research Ltd.
Subsidiary Financials FY 2019-20
PDF • Vanta Clinical Research Ltd.
Subsidiary Financials FY 2020-21
PDF • Vanta Clinical Research Ltd.
VAYAM RESEARCH SOLUTIONS LIMITED
Subsidiary Financials FY 2018-19
PDF • Vayam Research Solutions Ltd.
Subsidiary Financials FY 2019-20
PDF • Vayam Research Solutions Ltd.
Subsidiary Financials FY 2020-21
PDF • Vayam Research Solutions Ltd.
Subsidiary Financials FY 2021-22
PDF • Vayam Research Solutions Ltd.
Subsidiary Financials FY 2022-23
PDF • Vayam Research Solutions Ltd.
Subsidiary Financials FY 2023-24
PDF • Vayam Research Solutions Ltd.
Subsidiary Financials FY 2024-25
PDF • Vayam Research Solutions Ltd.
Corporate Announcements
YEAR: 2026
Intimation of BM for approval of Financials for year ended 31.03.2026
PDF • Updated 26.05.2026
Approval of financials for the half year and year ended 31.03.2026
PDF • Updated 30.05.2026
Clarification on Movement in Price
PDF • Updated 11.03.2026
Intimation of Compliances-Certificate
PDF • Updated 10.04.2026
YEAR: 2025
Intimation regarding closure of Trading Window for March 31,2025
PDF • Updated 29.03.2025
Intimation of receipt of GLP re-certification
PDF • Updated 02.05.2025
Intimation of Outcome of Board Meeting
PDF • Updated 06.05.2025
Submission of Disclosure under SEBI (SAST) Regulations
PDF • Updated 08.05.2025
Voting-Results-and-Scrutinizers-report-of-EGM-07.01.2025
PDF • Updated 08.05.2025
Intimation-of-Proceedings-of-EGM-04.01.2025.
PDF • Updated 08.05.2025
Intimation-of-Clarification-On-Movement-In-Price-11.03.2026
PDF • Updated 08.05.2025
Intimation-regarding-closure-of-Trading-Window-for-March-312025-29.03.2025
PDF • Updated 08.05.2025
Intimation-of-receipt-of-GLP-re-certification-02.05.2025
PDF • Updated 08.05.2025
Submission-of-Disclosure-under-SEBI-SAST-Regulations-08.05.2025
PDF • Updated 08.05.2025
Intimation-for-Board-meeting-Approval-of-financials-for-year-ended-31.03.2025
PDF • Updated 08.05.2025
Intimation-Delay-in-Financial-Results-29.05.2025
PDF • Updated 08.05.2025
Intimation-of-BM-for-approval-of-financial-statements-for-period-ended-31.03.2025-on-16.07.2025
PDF • Updated 08.05.2025
Intimation-regarding-postponement-of-BM-19.07.2025
PDF • Updated 08.05.2025
Intimation-regarding-postponement-of-BM-26.07.2025
PDF • Updated 08.05.2025
Intimation-regarding-postponement-of-BM-29.07.2025
PDF • Updated 08.05.2025
Intimation-of-Financials-For-Half-Year-And-Year-Ended-31.03.2025-01.08.2025
PDF • Updated 08.05.2025
Outcome-of-BM-to-hold-9th-AGM-06.09.2025.
PDF • Updated 08.05.2025
Intimation-of-Proceedings-of-9th-AGM-30.09.2025
PDF • Updated 08.05.2025
Intimation-regarding-closure-of-Trading-Window-–-Sept-302025
PDF • Updated 08.05.2025
Intimation-of-Disclosure-of-voting-results-of-the-9th-AGM-03.10.2025
PDF • Updated 08.05.2025
Intimation-of-resignation-of-Company-Secretary-and-Compliance-Officer-01.11.2025
PDF • Updated 08.05.2025
Intimation-of-Submission-of-Annual-Report-for-FY-2024-25-01.11.2025
PDF • Updated 08.05.2025
Intimation-to-hold-Board-Meeting-08.11.2025
PDF • Updated 08.05.2025
Intimation-of-Financial-results-for-half-year-ended-30.09.2025-14.11.2025.
PDF • Updated 08.05.2025
YEAR: 2024
Intimation regarding closure of Trading Window – March 31,2024
PDF • Updated March 2024
Intimation regarding Appointment of Company Secretary
PDF • Updated 01.04.2024
Approval of financials for the half year and year ended 31.03.2024
PDF • Updated 10.07.2024
Intimation-regarding-Compliance-Certificate-under-Regulation-409-of-SEBI-LODR-Regulations-21.04.2024
PDF • Updated 20.07.2024
IntImation-regarding-compliance-certificate-21.04.2024.
PDF • Updated 20.07.2024
Intimation-regarding-submission-of-Annual-Report-FY-2021-22-21.04.2024
PDF • Updated 20.07.2024
Intimation-regarding-Outcome-of-Board-Meeting-held-on-19.07.2024
PDF • Updated 20.07.2024
Intimation-regarding-postponement-of-Board-Meeting-17.07.2024
PDF • Updated 20.07.2024
Intimation-for-reclassification-from-Promoters-to-Public-Category-20.07.2024
PDF • Updated 20.07.2024
Intimation-of-Submission-of-Directors-resignation-letters-24.07.2024
PDF • Updated 20.07.2024
Intimation-of-submission-of-application-to-BSE-for-Reclassification-from-promoter-to-public-category-18.08.2024
PDF • Updated 20.07.2024
Intimation-of-Outcome-of-Board-Meeting-for-8th-AGM-06.09.2024
PDF • Updated 20.07.2024
Intimation-of-Submission-of-Annual-Report-for-FY-2023-24-06.09.2024
PDF • Updated 20.07.2024
Intimation-of-Submission-of-revised-financial-statements-for-period-ended-31.03.2024-19.09.2024
PDF • Updated 20.07.2024
Intimation-of-proceedings-of-8th-AGM-held-on-30.09.2024
PDF • Updated 20.07.2024
Intimation-regarding-closure-of-Trading-Window-–-Sept-302024
PDF • Updated 20.07.2024
Intimation-of-Voting-Results-and-Scrutinizers-report-for-8th-AGM-01.10.2024
PDF • Updated 20.07.2024
Intimation-of-Clarification-on-Movement-in-Price-07.11.2024
PDF • Updated 20.07.2024
Intimation-of-Unaudited-financial-results-for-half-year-ended-on-30.09.2024-14.11.2024
PDF • Updated 20.07.2024
Intimation-of-Board-Meeting-for-conversion-of-loan-to-equity-03.12.2024
PDF • Updated 20.07.2024
Intimation-of-outcome-of-Board-Meeting-06.12.2024
PDF • Updated 20.07.2024
Intimation-for-conducting-EGM-07.12.2024
PDF • Updated 20.07.2024
YEAR: 2023
Intimation regarding closure of Trading Window – March 31, 2023
PDF • Updated March 2023
Compliance Certificate under Regulation 7(3) of SEBI (LODR)
PDF • Updated 19.04.2023
Approval of financials for the half year and year ended 30.09.2022 and 31.03.2023 on 22.05.2023
PDF • Updated 22.05.2023
Intimation regarding Resignation of Company Secretary
PDF • Updated 10.07.2023
Voting-Results-and-Scrutinizers-report-for-the-6th-AGM-02.01.2023
PDF • Updated 10.07.2023
Appeal-filed-in-NCLAT-11.01.2023
PDF • Updated 10.07.2023
Intimation-of-the-First-Meeting-of-Committee-of-Creditors-14.01.2023
PDF • Updated 10.07.2023
Outcome-of-the-First-Meeting-of-Committee-of-Creditors-21.01.2023
PDF • Updated 10.07.2023
Settlement-with-the-Operational-Creditor-–-Order-of-Supreme-Court-15.02.2023
PDF • Updated 10.07.2023
Disclosure-under-Reg-30-of-SEBI-LODR-Regulation-2015-10.03.2023
PDF • Updated 10.07.2023
Intimation-regarding-closure-of-Trading-Window-–-March-312023
PDF • Updated 10.07.2023
Compliance-Certificate-under-Regulation-73-of-SEBI-LODR-19.04.2023
PDF • Updated 10.07.2023
Compliance-Certificate-under-Regulation-409-of-SEBI-LODR-30.04.2023
PDF • Updated 10.07.2023
Confirmation-regarding-not-being-a-Large-Corporate-30.04.2023
PDF • Updated 10.07.2023
Approval-of-financials-for-the-half-year-and-year-ended-30.09.2022-and-31.03.2023-on-22.05.2023
PDF • Updated 10.07.2023
Intimation-regarding-postponement-of-Board-Meeting-30.05.2023
PDF • Updated 10.07.2023
Intimation-regarding-Resignation-of-Company-Secretary-10.07.2023
PDF • Updated 10.07.2023
Intimation-for-Board-meeting-Approval-of-financials-for-half-year-and-year-ended-30.09.2022-and-31.03.2023-on-04.08.2023
PDF • Updated 10.07.2023
Approval-of-financials-for-the-half-year-and-year-ended-30.09.2022-and-31.03.2023-on-10.08.2023
PDF • Updated 10.07.2023
Financial-Results-for-the-half-year-and-year-ended-31.03.2023-10.08.2023
PDF • Updated 10.07.2023
Financial-Results-for-the-period-ended-30.09.2022-10.08.2023
PDF • Updated 10.07.2023
Intimation-of-7th-Annual-General-Meeting-06.09.2023
PDF • Updated 10.07.2023
Intimation-regarding-closure-of-Trading-Window-–-Sept-302023
PDF • Updated 10.07.2023
Intimation-of-Proceedings-of-the-7th-Annual-General-Meeting-01.10.2023
PDF • Updated 10.07.2023
Intimation-of-Voting-Results-and-Scrutinizers-report-for-the-7th-AGM-04.10.2023
PDF • Updated 10.07.2023
Intimation-of-Submission-of-Annual-Report-for-the-financial-year-2022-23-16.10.2023
PDF • Updated 10.07.2023
Intimation-regarding-closure-of-CIRP-Process-02.11.2023
PDF • Updated 10.07.2023
ntimation-for-Board-meeting-Approval-of-unaudited-financials-for-half-year-ended-30.09.2023-on-08.11.2023
PDF • Updated 10.07.2023
Intimation-of-outcome-of-Board-meeting-Approval-of-unaudited-financials-for-half-year-ended-30.09.2023-14.11.2023
PDF • Updated 10.07.2023
ntimation-of-Receipt-of-order-worth-Rs.-57-Lakh-for-GLP-Studies-01.12.2023
PDF • Updated 10.07.2023
YEAR: 2022
Intimation regarding closure of Trading Window – March 31,2022
PDF • Updated March 2022
Intimation regarding Admission of Application and Initiation of CIRP Process
PDF • Compliance Document
Stay order by High Court of Telangana on insolvency proceedings
PDF • Updated 03.06.2022
Appeal filed in NCLAT – 15.06.2022 and hearing on 16.06.2022
PDF • Updated 16.06.2022
Update-in-the-matter-of-NCLT-C.P.-IB-2152021-Filed-Against-The-Company-Hearing-dated-16.02.2022
PDF • Updated 16.06.2022
Update-in-the-matter-of-NCLT-C.P.-IB-2152021-Filed-Against-The-Company-Hearing-dated-01.03.2022
PDF • Updated 16.06.2022
Update-in-the-matter-of-NCLT-C.P.-IB-2152021-Filed-Against-The-Company-Hearing-dated-08.03.2022
PDF • Updated 16.06.2022
Intimation-regarding-closure-of-Trading-Window-March-312022
PDF • Updated 16.06.2022
Update-in-the-matter-of-NCLT-C.P.-IB-2152021-Filed-Against-The-Company-Hearing-dated-28.03.2022
PDF • Updated 16.06.2022
Intimation-regarding-Admission-of-Application-and-Initiation-of-CIRP-Process
PDF • Updated 16.06.2022
Admission-of-Application_-appointment-of-IRP-and-Public-Annoucement
PDF • Updated 16.06.2022
Intimation-regarding-date-of-approval-of-financials-for-the-half-year-and-year-ended-31.03.2022-30.05.2022
PDF • Updated 16.06.2022
Intimation-of-the-First-Meeting-of-Committee-of-Creditors-on-31.05.2022
PDF • Updated 16.06.2022
Stay-order-by-High-Court-of-Telangana-on-insolvency-proceedings-03.06.2022
PDF • Updated 16.06.2022
Appeal-filed-in-NCLAT-15.06.2022-and-hearing-on-16.06.2022
PDF • Updated 16.06.2022
Appeal-filed-in-NCLAT-Updates-regarding-hearings-on-June-16-2022-and-June-17-23.06.2022
PDF • Updated 16.06.2022
Appeal-filed-in-NCLAT-Updates-regarding-hearings-on-July-20-2022-28.07.2022
PDF • Updated 16.06.2022
Appeal-filed-in-NCLAT-Updates-regarding-hearing-on-August-11-2022-17.08.2022.
PDF • Updated 16.06.2022
Application-to-ROC-for-AGM-Extension-and-Resignation-of-Company-Secretary-03.09.2022
PDF • Updated 16.06.2022
Receipt-of-approval-from-ROC-granting-extension-for-holding-6th-AGM-07.09.2022
PDF • Updated 16.06.2022
Appointment-of-CS-and-Compliance-Officer-15.09.2022
PDF • Updated 16.06.2022
Intimation-regarding-closure-of-Trading-Window-–-Sept-302022
PDF • Updated 16.06.2022
Approval-of-un-audited-financials-for-the-half-year-and-year-ended-30.09.2022-on-08.11.2022
PDF • Updated 16.06.2022
Intimation-regarding-delay-in-submission-of-financial-results-for-the-half-year-14.11.2022
PDF • Updated 16.06.2022
Appeal-filed-in-NCLAT-24.11.2022
PDF • Updated 16.06.2022
Appeal-filed-in-NCLAT-27.11.2022
PDF • Updated 16.06.2022
Annual-General-Meeting-07.12.2022
PDF • Updated 16.06.2022
Appeal-filed-in-NCLAT-14.12.2022
PDF • Updated 16.06.2022
Proceedings-of-the-6th-AGM-31.12.2022
PDF • Updated 16.06.2022
YEAR: 2021
Intimation Regarding Application Filed Against The Company Before NCLT
PDF • Updated June 2021
Intimation of Board Meeting on June 23, 2021
PDF • Updated 23.06.2021
Outcome of Board Meeting on June 28, 2021
PDF • Updated 28.06.2021
Grant-Of-Registration-By-DCGI-To-Vayam-Research-Solutions-Limited
PDF • Updated 28.06.2021
Vayam-Research-Solutions-Limited-Ceases-To-Be-A-Step-Down-Subsidiary
PDF • Updated 28.06.2021
Intimation-Regarding-Application-Filed-Against-The-Company-Before-NCLT
PDF • Updated 28.06.2021
Intimation-of-Board-Meeting-on-June-23-2021
PDF • Updated 28.06.2021
Rescheduling-of-Board-Meeting-to-June-28-2021
PDF • Updated 28.06.2021
Intimation-Regarding-NABLS-Recommendation-To-Continue-The-Biological-Testing-Accreditation-Granted-To-The-Company
PDF • Updated 28.06.2021
Intimation-Regarding-GLP-Re-Certification-In-VBS-And-Commencement-Of-Commercial-Operations-In-Vayam
PDF • Updated 28.06.2021
Intimation-regarding-application-for-extension-Of-Time-To-Hold-The-5Th-AGM-Of-The-Company
PDF • Updated 28.06.2021
Intimation-regarding-Receipt-Of-Full-Accreditation-Status-From-AAALAC-International-USA
PDF • Updated 28.06.2021
Intimation-regardin-Approval-From-Registrar-Of-Companies-Granting-Extension-Of-Time-For-Holding-The-5Th-AGM
PDF • Updated 28.06.2021
Update-in-the-matter-of-NCLT-C.P.-IB-2152021-Filed-Against-The-Company-Hearing-dated-24.09.2021
PDF • Updated 28.06.2021
Closure-of-Trading-Window-September-2021
PDF • Updated 28.06.2021
Update-in-the-matter-of-NCLT-C.P.-IB-2152021-Filed-Against-The-Company-Hearing-dated-27.10.2021
PDF • Updated 28.06.2021
Intimation-of-Board-Meeting-to-be-held-on-November-11-2021
PDF • Updated 28.06.2021
Intimation-regarding-Expansion-Of-Scope-Of-GLP-Certification
PDF • Updated 28.06.2021
Update-in-the-matter-of-NCLT-C.P.-IB-2152021-Filed-Against-The-Company-Hearing-dated-22.11.2021
PDF • Updated 28.06.2021
Outcome-of-Board-Meeting-dated-December-06-2021-AGM-on-31.12.2021
PDF • Updated 28.06.2021
Proceedings-of-AGM-held-on-31.12.2021
PDF • Updated 28.06.2021
Update-in-the-matter-of-NCLT-C.P.-IB-2152021-Filed-Against-The-Company-Hearing-dated-22.12.2021
PDF • Updated 28.06.2021
Press Release
Newspaper Publications
Notice of EGM to be held on February 07th, 2018
PDF • Public Notice
Notice of AGM to be held on August 21, 2018
PDF • Public Notice
Notice and corrigendum of EGM to be held on September 29, 2018
PDF • Public Notice
Notice of 3rd AGM to be held on September 27, 2019
PDF • Public Notice
Current Status
Last Updated: August 19, 2026
Stock Price
₹245.80
Market Cap
₹12,400 Cr
P/E Ratio
28.5x
52W Range
₹185 – ₹310
Vanta Bioscience Limited is a premier GLP-compliant preclinical contract research organization (CRO). Vanta Bioscience is publically listed and adheres strictly to corporate regulatory frameworks, financial disclosures, and the highest standards of governance requested by security and exchange regulatory boards.
Shareholding Pattern
Shareholding Pattern — As on Oct 06th, 2017
PDF • Regulatory Shareholding Statement
Shareholding Pattern — As on March 31st, 2018
PDF • Regulatory Shareholding Statement
Shareholding Pattern — As on September 30th, 2018
PDF • Regulatory Shareholding Statement
Shareholding Pattern — As on March 31, 2019
PDF • Regulatory Shareholding Statement
Shareholding Pattern — As on September 30th, 2019
PDF • Regulatory Shareholding Statement
Shareholding Pattern — As on March 31, 2020
PDF • Regulatory Shareholding Statement
Shareholding Pattern — As on September 30, 2020
PDF • Regulatory Shareholding Statement
Shareholding Pattern — As on March 31, 2021
PDF • Regulatory Shareholding Statement
Shareholding Pattern — As on September 30, 2021
PDF • Regulatory Shareholding Statement
Shareholding Pattern — As on March 31, 2022
PDF • Regulatory Shareholding Statement
Shareholding Pattern — As on September 30, 2022
PDF • Regulatory Shareholding Statement
Shareholding Pattern — As on March 31, 2023
PDF • Regulatory Shareholding Statement
Shareholding Pattern — As on September 30, 2023
PDF • Regulatory Shareholding Statement
Shareholding Pattern — As on March 31, 2024
PDF • Regulatory Shareholding Statement
Shareholding Pattern — As on September 30, 2024
PDF • Regulatory Shareholding Statement
Shareholding Pattern — As on March 31, 2025
PDF • Regulatory Shareholding Statement
Shareholding Pattern — As on September 30, 2025
PDF • Regulatory Shareholding Statement
Shareholding Pattern — As on March 31, 2026
PDF • Regulatory Shareholding Statement
Prospectus
Company Prospectus
PDF • Corporate Prospectus & IPO Details
Preferential Allotment
Notice of EGM to be held on 04.01.2025
PDF • Regulatory Allotment Compliance
Have Questions? Get in Touch
Can’t find the specific resource, code template, or compliance documentation you need?
Our team of professional architects is ready to assist you.